Clinical trial · Interventional
Evaluation of Double Tract Reconstruction After Total Gastrectomy in Patients With Gastric Cancer
A Prospective Randomized Controlled Trial Comparing Double Tract Method With Roux-en-Y Method After Total Gastrectomy in Patients With Gastric Cancer
NCT00746161CI-TRIAL-00001665completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the double tract reconstruction after total gastrectomy in patients with gastric cancer. A prospective randomized controlled trial was conducted to compare double tract method with Roux-en-Y method
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Reconstruction after total gastrectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- 1
- description
- Roux-en-Y
- interventionNames
- Procedure: Reconstruction after total gastrectomy
- type
- EXPERIMENTAL
- label
- 2
- description
- double tract reconstruction
- interventionNames
- Procedure: Reconstruction after total gastrectomy
Primary outcomes (1)
- measure
- The %body weight ratio
- timeFrame
- 12 months after operation
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically proven adenocarcinoma without esophageal invasion, tumor status T1-2 * Age 80 years or younger * No distant metastasis Exclusion Criteria: * Carcinoma in the remnant stomach * Stage intravenous (IV) * History of laparotomy * History of serious heart disease * Liver cirrhosis or chronic liver disease with indocyanine green excretion test at 15 min of 15% or more * Absence of informed consent
References
Publications (1)
- DERIVEDIwahashi M, Nakamori M, Nakamura M, Naka T, Ojima T, Iida T, Katsuda M, Ueda K, Yamaue H. Evaluation of double tract reconstruction after total gastrectomy in patients with gastric cancer: prospective randomized controlled trial. World J Surg. 2009 Sep;33(9):1882-8. doi: 10.1007/s00268-009-0109-0. PMID 19548028